{"id":"https://openalex.org/W1580428367","doi":"https://doi.org/10.1111/j.1440-1819.2007.01739.x","title":"Successful treatment of Meige's syndrome induced by risperidone and fluvoxamine with olanzapine monotherapy in schizophrenia","display_name":"Successful treatment of Meige's syndrome induced by risperidone and fluvoxamine with olanzapine monotherapy in schizophrenia","publication_year":2007,"publication_date":"2007-12-01","ids":{"openalex":"https://openalex.org/W1580428367","doi":"https://doi.org/10.1111/j.1440-1819.2007.01739.x","mag":"1580428367","pmid":"https://pubmed.ncbi.nlm.nih.gov/18081639"},"language":"en","primary_location":{"id":"doi:10.1111/j.1440-1819.2007.01739.x","doi":"https://doi.org/10.1111/j.1440-1819.2007.01739.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1440-1819.2007.01739.x","pdf_url":null,"source":{"id":"https://openalex.org/S111042112","display_name":"Psychiatry and Clinical Neurosciences","issn_l":"1323-1316","issn":["1323-1316","1440-1819"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychiatry and Clinical Neurosciences","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021387749","display_name":"Seiya Miyamoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I163917720","display_name":"St. Marianna University School of Medicine","ror":"https://ror.org/043axf581","country_code":"JP","type":"education","lineage":["https://openalex.org/I163917720"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"SEIYA MIYAMOTO","raw_affiliation_strings":["Department of Neuropsychiatry, St Marianna University School of Medicine, Kawasaki, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuropsychiatry, St Marianna University School of Medicine, Kawasaki, Japan","institution_ids":["https://openalex.org/I163917720"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064499343","display_name":"Nobumi Miyake","orcid":"https://orcid.org/0000-0001-8694-5643","observed_orcids":["https://orcid.org/0000-0001-8694-5643"]},"institutions":[{"id":"https://openalex.org/I163917720","display_name":"St. Marianna University School of Medicine","ror":"https://ror.org/043axf581","country_code":"JP","type":"education","lineage":["https://openalex.org/I163917720"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"NOBUMI MIYAKE","raw_affiliation_strings":["Department of Neuropsychiatry, St Marianna University School of Medicine, Kawasaki, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuropsychiatry, St Marianna University School of Medicine, Kawasaki, Japan","institution_ids":["https://openalex.org/I163917720"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108367353","display_name":"Shin Ogino","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I163917720","display_name":"St. Marianna University School of Medicine","ror":"https://ror.org/043axf581","country_code":"JP","type":"education","lineage":["https://openalex.org/I163917720"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"SHIN. OGINO","raw_affiliation_strings":["Department of Neuropsychiatry, St. Marianna University School of Medicine Kawasaki, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuropsychiatry, St. Marianna University School of Medicine Kawasaki, Japan","institution_ids":["https://openalex.org/I163917720"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021335751","display_name":"Takako Endo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I163917720","display_name":"St. Marianna University School of Medicine","ror":"https://ror.org/043axf581","country_code":"JP","type":"education","lineage":["https://openalex.org/I163917720"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"TAKAKO ENDO","raw_affiliation_strings":["Department of Neuropsychiatry, St Marianna University School of Medicine, Kawasaki, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuropsychiatry, St Marianna University School of Medicine, Kawasaki, Japan","institution_ids":["https://openalex.org/I163917720"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5073461178","display_name":"Noboru Yamaguchi","orcid":"https://orcid.org/0000-0002-2506-8373","observed_orcids":["https://orcid.org/0000-0002-2506-8373"]},"institutions":[{"id":"https://openalex.org/I163917720","display_name":"St. Marianna University School of Medicine","ror":"https://ror.org/043axf581","country_code":"JP","type":"education","lineage":["https://openalex.org/I163917720"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"NOBORU YAMAGUCHI","raw_affiliation_strings":["Department of Neuropsychiatry, St Marianna University School of Medicine, Kawasaki, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuropsychiatry, St Marianna University School of Medicine, Kawasaki, Japan","institution_ids":["https://openalex.org/I163917720"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I163917720"],"apc_list":{"value":3240,"currency":"USD","value_usd":3240},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"61","issue":"6","first_page":"702","last_page":"703"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.7598000168800354,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.7598000168800354,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11274","display_name":"Botulinum Toxin and Related Neurological Disorders","score":0.09839999675750732,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13966","display_name":"Neurological and metabolic disorders","score":0.03790000081062317,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/meige-syndrome","display_name":"Meige syndrome","score":0.9929999709129333},{"id":"https://openalex.org/keywords/blepharospasm","display_name":"blepharospasm","score":0.8460000157356262},{"id":"https://openalex.org/keywords/oromandibular-dystonia","display_name":"oromandibular dystonia","score":0.921999990940094},{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":0.8130000233650208},{"id":"https://openalex.org/keywords/fluvoxamine","display_name":"fluvoxamine","score":0.996999979019165},{"id":"https://openalex.org/keywords/olanzapine","display_name":"olanzapine","score":0.9369999766349792},{"id":"https://openalex.org/keywords/drug-induced-movement-disorders","display_name":"drug-induced movement disorders","score":0.6930000185966492},{"id":"https://openalex.org/keywords/antipsychotic-side-effects","display_name":"antipsychotic adverse effects","score":0.7540000081062317},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.6819999814033508},{"id":"https://openalex.org/keywords/first-episode-schizophrenia","display_name":"first-episode schizophrenia","score":0.7559999823570251},{"id":"https://openalex.org/keywords/focal-dystonia","display_name":"focal dystonia","score":0.6269999742507935},{"id":"https://openalex.org/keywords/antipsychotic-switching","display_name":"antipsychotic switching","score":0.5400000214576721},{"id":"https://openalex.org/keywords/negative-symptoms","display_name":"negative symptoms","score":0.5659999847412109},{"id":"https://openalex.org/keywords/dopamine-receptor-antagonists","display_name":"dopamine antagonists","score":0.5899999737739563},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.8159999847412109}],"concepts":[{"id":"https://openalex.org/C2780057945","wikidata":"https://www.wikidata.org/wiki/Q412443","display_name":"Risperidone","level":3,"score":0.8108497858047485},{"id":"https://openalex.org/C2779910183","wikidata":"https://www.wikidata.org/wiki/Q409236","display_name":"Fluvoxamine","level":5,"score":0.6039587259292603},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5952699184417725},{"id":"https://openalex.org/C2778817116","wikidata":"https://www.wikidata.org/wiki/Q883863","display_name":"Blepharospasm","level":3,"score":0.5914356708526611},{"id":"https://openalex.org/C2778559928","wikidata":"https://www.wikidata.org/wiki/Q906492","display_name":"Dystonia","level":2,"score":0.587059736251831},{"id":"https://openalex.org/C2776619155","wikidata":"https://www.wikidata.org/wiki/Q201872","display_name":"Olanzapine","level":3,"score":0.5387891530990601},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.43076929450035095},{"id":"https://openalex.org/C2780634440","wikidata":"https://www.wikidata.org/wiki/Q408535","display_name":"Quetiapine","level":3,"score":0.42954716086387634},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.41388726234436035},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.38589367270469666},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.36024218797683716},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.34631264209747314},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3237990736961365},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.16233891248703003},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000077152","descriptor_name":"Olanzapine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008538","descriptor_name":"Meige Syndrome","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D008538","descriptor_name":"Meige Syndrome","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D008538","descriptor_name":"Meige Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016666","descriptor_name":"Fluvoxamine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D016666","descriptor_name":"Fluvoxamine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1440-1819.2007.01739.x","doi":"https://doi.org/10.1111/j.1440-1819.2007.01739.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1440-1819.2007.01739.x","pdf_url":null,"source":{"id":"https://openalex.org/S111042112","display_name":"Psychiatry and Clinical Neurosciences","issn_l":"1323-1316","issn":["1323-1316","1440-1819"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychiatry and Clinical Neurosciences","raw_type":"journal-article"},{"id":"pmid:18081639","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18081639","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychiatry and clinical neurosciences","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":4,"referenced_works":["https://openalex.org/W115485700","https://openalex.org/W1983433918","https://openalex.org/W2078147824","https://openalex.org/W2154860023"],"related_works":["https://openalex.org/W2519032277","https://openalex.org/W7208306723","https://openalex.org/W4376890438","https://openalex.org/W2154860023","https://openalex.org/W115485700","https://openalex.org/W2990296051","https://openalex.org/W2332373620","https://openalex.org/W2522120086","https://openalex.org/W1835064950","https://openalex.org/W2625838610"],"abstract_inverted_index":{"Meige's":[0,64,404,430,521,567],"syndrome":[1,35,65,405,522],"is":[2,16,398,406],"a":[3,61,103,176,370,436,518,562],"focal":[4],"dystonia":[5,445],"characterized":[6],"by":[7,45,408,470],"symmetrical":[8],"blepharospasm":[9,240,310,324,345],"and":[10,55,75,110,118,132,144,190,217,237,248,256,294,346,377,413,461,506,586],"oromandibular":[11],"dystonia.1":[12],"Its":[13],"typical":[14],"feature":[15],"difficulty":[17,243,278],"in":[18,83,179,244,279,311,361,488,542,565],"opening":[19,280],"the":[20,26,31,148,266,285,321,358,399,441,449,465,471,501,513,529,554],"eyelids,":[21],"resulting":[22],"from":[23,160],"involvement":[24],"of":[25,33,63,92,99,106,138,147,172,219,235,268,277,308,317,323,331,342,373,440,443,467,503],"bilateral":[27],"orbicularis":[28],"muscle.":[29],"Although":[30],"causes":[32],"this":[34,204,391,397,496,584],"are":[36,580],"unknown,":[37],"it":[38],"has":[39,425,523,538],"been":[40,426,435,524],"reported":[41,175,427,525],"to":[42,69,90,165,198,229,260,291,300,336,389,428,482,495,500,526,539,582],"be":[43,493,540],"induced":[44,407],"dopamine":[46],"agonists":[47],"or":[48,420],"antagonists,":[49],"cerebellar":[50],"degeneration,":[51],"basal":[52],"ganglia":[53],"dysfunction,":[54],"brain":[56,149],"tumors.2":[57],"We":[58,223,333],"now":[59],"report":[60,401],"case":[62,392,438,451,552],"that":[66,403,479,558],"was":[67,78,115,122,130,134,194,254,258,270,298,325,353,369,515],"secondary":[68],"combined":[70,409],"treatment":[71,173,318,410,536],"with":[72,81,102,305,319,411,422,446],"low-dose":[73,414],"risperidone":[74,158,236,257,293,468],"fluvoxamine,":[76,238,453],"which":[77,454],"successfully":[79],"treated":[80],"olanzapine":[82,301,320,335,559],"first-episode":[84],"schizophrenia.":[85,489],"A":[86],"33-year-old":[87],"man":[88],"came":[89],"Department":[91],"Neuropsychiatry":[93],"at":[94,203,517],"St":[95],"Marianna":[96],"University":[97],"School":[98],"Medicine":[100],"Hospital":[101],"1.5-year":[104],"history":[105,129,137],"persistent":[107],"persecutory":[108],"delusion":[109],"auditory":[111],"hallucination.":[112],"His":[113,127,141,252],"mood":[114],"not":[116,125,151,271],"depressed,":[117],"his":[119,180,281,295,309,344,363,374,386],"thought":[120],"process":[121],"logical":[123],"but":[124,183,328],"fluent.":[126],"medical":[128],"uneventful,":[131],"there":[133,368,433],"no":[135,378],"family":[136],"movement":[139],"disorders.":[140],"laboratory":[142],"examination":[143],"computed":[145],"tomography":[146],"did":[150],"show":[152],"any":[153],"abnormalities.":[154],"He":[155,288],"started":[156],"receiving":[157],"monotherapy":[159],"3":[161],"mg/day,":[162],"increasing":[163],"up":[164],"4":[166],"mg/day":[167,228,303],"thereafter.":[168],"After":[169,201,314,339],"2":[170,199],"months":[171,316],"he":[174,274,329],"complete":[177],"reduction":[178],"psychotic":[181,364],"symptoms,":[182],"experienced":[184],"side-effects":[185,380],"such":[186,212],"as":[187,213,355,357],"decreased":[188,197,259,334],"libido":[189],"ejaculatory":[191],"deficit.":[192],"Risperidone":[193,416],"then":[195,289],"gradually":[196],"mg/day.":[200,262,338],"being":[202],"dose":[205],"for":[206,573],"5":[207,337],"months,":[208],"predominant":[209],"negative":[210,375,486],"symptoms":[211,376,487],"social":[214],"withdrawal,":[215],"avolition":[216],"lack":[218],"interest":[220],"were":[221,349,381,532],"observed.":[222,382],"thus":[224],"added":[225],"fluvoxamine":[226,253,412,481],"50":[227],"risperidone.":[230,415],"Two":[231],"days":[232],"after":[233],"coadministration":[234],"severe":[239],"(excessive":[241],"blinking,":[242],"seeing,":[245],"facial":[246],"grimacing)":[247],"tongue":[249,347],"tremor":[250,348],"appeared.":[251],"withdrawn":[255],"1":[261],"One":[263],"week":[264],"later":[265],"change":[267],"medication":[269,296],"satisfactory":[272],"because":[273],"still":[275],"complained":[276,330],"eyes,":[282],"especially":[283],"on":[284],"left":[286],"side.":[287],"decided":[290],"stop":[292],"regimen":[297,360],"changed":[299],"10":[302,312],"monotherapy,":[304],"significant":[306],"resolution":[307],"days.":[313],"two":[315],"improvement":[322,372,442],"more":[326],"evident":[327],"somnolence.":[332],"another":[340],"couple":[341],"weeks":[343],"completely":[350],"relieved.":[351],"Olanzapine":[352],"also":[354],"effective":[356],"previous":[359,555],"controlling":[362],"symptoms.":[365],"In":[366,448],"addition":[367],"marked":[371],"other":[379,423],"The":[383,550,569],"patient":[384],"gave":[385],"informed":[387],"consent":[388],"permit":[390],"report.":[393],"To":[394],"our":[395],"knowledge":[396],"first":[400],"demonstrating":[402,557],"administered":[417],"either":[418],"alone":[419],"concomitantly":[421],"antipsychotics":[424,483,531],"induce":[429],"syndrome,":[431],"although":[432],"have":[434,477,561],"few":[437],"reports":[439,556],"tardive":[444],"risperidone.3":[447],"present":[450,551],"coadministering":[452],"can":[455,484],"potently":[456],"inhibit":[457],"cytochrome":[458],"P450":[459],"(CYP)2D6":[460],"CYP3A4,":[462],"might":[463],"increase":[464],"levels":[466],"metabolized":[469],"CYP":[472],"isoenzymes.":[473],"Several":[474],"placebo-controlled":[475],"trials":[476],"shown":[478],"adding":[480],"improve":[485,527],"However,":[490,534],"caution":[491],"should":[492],"paid":[494],"adjunctive":[497],"strategy":[498],"due":[499],"risk":[502],"drug":[504],"interactions":[505],"subsequent":[507],"unpredictable":[508],"adverse":[509],"events,":[510],"even":[511],"if":[512],"antipsychotic":[514,535],"given":[516],"low":[519],"dose.":[520],"when":[528],"offending":[530],"discontinued.4":[533],"often":[537],"continued":[541],"those":[543],"schizophrenia":[544],"patients":[545],"who":[546],"require":[547],"maintenance":[548],"treatment.":[549],"supports":[553],"may":[560],"beneficial":[563],"effect":[564,585],"ameliorating":[566],"syndrome.5":[568],"precise":[570],"pharmacophysiologic":[571],"basis":[572],"its":[574,587],"effectiveness":[575],"remains":[576],"unknown.":[577],"Further":[578],"studies":[579],"necessary":[581],"examine":[583],"mechanism.":[588]},"counts_by_year":[{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}